Locations

Our
Locations

Immatics operates as a transatlantic organization with the team spanning from Tübingen and Munich, Germany to Houston, Texas. The long-term integration of the European and US sites also brings the advantage that Immatics has built a highly functioning team across two continents with access to two important markets for medical innovation.

Since its foundation in 2000 as a spin out from H.G. Rammensee’s laboratory at University of Tübingen, Germany, Immatics has revolutionized the identification of tumor-associated pHLA targets, which are recognized by T cells. Identifying true cancer targets that are presented on tumor tissue but not on healthy cells and the subsequent discovery, selection, and engineering of a therapeutic TCR are central to Immatics‘ mission: Delivering the power of T cells to cancer patients and advance the next wave in cancer immunotherapy.

In 2015, Immatics and MD Anderson Cancer Center launched Immatics US, Inc. in Houston, Texas as a joint venture to develop transformative Adoptive Cell Therapies.

Immatics US, Inc.

2201 West Holcombe Blvd., Suite 205, Houston, Texas 77030

Business line: +1 346 204-5400, Fax line: +1 346 204-5931
E-Mail: info@immatics.com

Immatics Biotechnologies GmbH

Paul-Ehrlich-Str. 15, 72076 Tuebingen, Germany

Phone: +49 7071 5397-0, Fax: +49 7071 5397-900
E-Mail: info@immatics.com

Immatics Biotechnologies GmbH

Machtlfinger Str. 11, 81379 Munich, Germany

Phone: +49 89 540415-0, Fax: +49 89 540415-905
E-Mail: info@immatics.com

Our
Locations

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close